KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Humana (HUM) Net Income towards Common Stockholders (2016 - 2025)

Humana (HUM) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with -$762.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders changed N/A to -$762.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 billion, a N/A change, with the full-year FY2025 number at $1.3 billion, changed 0.23% from a year prior.
  • Net Income towards Common Stockholders was -$762.0 million for Q4 2025 at Humana, down from $426.0 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $1.5 billion in Q3 2021 to a low of -$762.0 million in Q4 2025.
  • A 4-year average of $665.7 million and a median of $787.0 million in 2023 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: tumbled 69.22% in 2021, then soared 78.52% in 2023.
  • Humana's Net Income towards Common Stockholders stood at -$83.0 million in 2021, then rose by 13.25% to -$72.0 million in 2022, then soared by 1193.06% to $787.0 million in 2023, then tumbled by 196.82% to -$762.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Net Income towards Common Stockholders are -$762.0 million (Q4 2025), $426.0 million (Q3 2025), and $501.0 million (Q2 2025).